A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis

Stopped Not due to safety concerns, but changes in strategy which this trial no longer fulfills.

Conditions

• Ulcerative Colitis

Interventions

• DRUG: Microbiota suspension
• DRUG: Microbiota capsule
• DRUG: Placebo suspension
• DRUG: Placebo capsule

Sponsor

Ferring Pharmaceuticals